Offers Sep 2016 Report package: T-Cell Immunotherapy by bispecific antibodies and CAR & TCR engineered T-cells 3,000.00 € 4,500.00 €(Discount: 33.33%) May 2018 Report Package: TCR-Based Antibody and T-Cell Immunotherapy 2,966.67 € 4,450.00 €(Discount: 33.33%) Jun 2018 R&D Drug Pipeline Database: 1-Year Subscription 6,000.00 € Oct 2017 Report Package: Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics 3,080.00 € 4,400.00 €(Discount: 30.00%) Dec 2016 Report Package: Hot targets for empowered antibody and cell therapy technologies 1,140.00 € 1,900.00 €(Discount: 40.00%) Jul 2018 Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators 1,440.00 € 2,400.00 €(Discount: 40.00%) Jun 2016 Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors 3,100.00 € 6,200.00 €(Discount: 50.00%) Nov 2016 Flat-Rate Access to R&D Database & Reports from La Merie Publishing 7,000.00 €
Sep 2016 Report package: T-Cell Immunotherapy by bispecific antibodies and CAR & TCR engineered T-cells 3,000.00 € 4,500.00 €(Discount: 33.33%)
May 2018 Report Package: TCR-Based Antibody and T-Cell Immunotherapy 2,966.67 € 4,450.00 €(Discount: 33.33%)
Oct 2017 Report Package: Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics 3,080.00 € 4,400.00 €(Discount: 30.00%)
Dec 2016 Report Package: Hot targets for empowered antibody and cell therapy technologies 1,140.00 € 1,900.00 €(Discount: 40.00%)
Jul 2018 Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators 1,440.00 € 2,400.00 €(Discount: 40.00%)
Jun 2016 Therapeutic Antibody Reports Bundle: ADCs, Bispecifics, Biosimilars & Biosuperiors 3,100.00 € 6,200.00 €(Discount: 50.00%)
